These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2987633)

  • 1. [LAV/HTLV-III--new discoveries on its properties, isolation, vaccination and therapy].
    Asjö B; Morfeldt-Månson L; Fenyö EM; Böttiger B; Biberfeld G; Espmark A
    Lakartidningen; 1985 May; 82(20):1870-5. PubMed ID: 2987633
    [No Abstract]   [Full Text] [Related]  

  • 2. [Possibilities of vaccine prevention and virostatic therapy in HTLV-III/LAV infection].
    Goebel FD
    Verh Dtsch Ges Inn Med; 1986; 92():341-3. PubMed ID: 3643689
    [No Abstract]   [Full Text] [Related]  

  • 3. [AIDS HTLV III/LAV infection. Why is it so difficult to make a vaccine?].
    Dobloug JH
    Tidsskr Nor Laegeforen; 1986 Aug; 106(22):1674-6. PubMed ID: 3775696
    [No Abstract]   [Full Text] [Related]  

  • 4. The search for an AIDS vaccine.
    Dowdle W
    Public Health Rep; 1986; 101(3):232-3. PubMed ID: 3012619
    [No Abstract]   [Full Text] [Related]  

  • 5. [AIDS--possibilities for vaccine and antiviral therapy].
    Grinde B; Hungnes O; Tjøtta E
    Tidsskr Nor Laegeforen; 1988 Jun; 108(17-18):1413-5. PubMed ID: 3388373
    [No Abstract]   [Full Text] [Related]  

  • 6. What are we going to do about AIDS and HTLV-III/LAV infection?
    Merigan TC
    N Engl J Med; 1984 Nov; 311(20):1311-3. PubMed ID: 6092955
    [No Abstract]   [Full Text] [Related]  

  • 7. Toward a vaccine against AIDS: rationale and current progress.
    Fischinger PJ; Gallo RC; Bolognesi DP
    Mt Sinai J Med; 1986 Dec; 53(8):639-47. PubMed ID: 3027544
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [LAV type II: a second retrovirus associated with AIDS in West Africa].
    Clavel F; Brun-Vézinet F; Guétard D; Chamaret S; Laurent A; Rouzioux C; Rey M; Katlama C; Rey F; Champelinaud JL
    C R Acad Sci III; 1986; 302(13):485-8. PubMed ID: 3013382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sero-epidemiology of HTLV-III/LAV antibodies in French-speaking Switzerland].
    Stroun J
    Rev Med Suisse Romande; 1985 Nov; 105(11):1055-7. PubMed ID: 3003866
    [No Abstract]   [Full Text] [Related]  

  • 11. Acquired immune deficiency syndrome (AIDS) HTLV III/LAV; the causal agent and modes of transmission.
    Smithies A
    Health Bull (Edinb); 1986 Jul; 44(4):234-8. PubMed ID: 3017891
    [No Abstract]   [Full Text] [Related]  

  • 12. Unconventional vaccines: immunization with anti-idiotype antibody against viral diseases.
    Koprowski H
    Cancer Res; 1985 Sep; 45(9 Suppl):4689s-4690s. PubMed ID: 2990707
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation of LAV/HTLV-III from a patient with amyotrophic lateral sclerosis.
    Hoffman PM; Festoff BW; Giron LT; Hollenbeck LC; Garruto RM; Ruscetti FW
    N Engl J Med; 1985 Aug; 313(5):324-5. PubMed ID: 2989688
    [No Abstract]   [Full Text] [Related]  

  • 14. [Properties and transmission of the AIDS virus].
    Laufs R
    Hautarzt; 1986 May; 37(5):245-9. PubMed ID: 3015839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preventive measures against HTLV-III/LAV infections among hemophiliacs and their relatives].
    Evensen SA; Frøland SS; Glomstein A
    Tidsskr Nor Laegeforen; 1986 Jan; 106(1):19-21. PubMed ID: 3006278
    [No Abstract]   [Full Text] [Related]  

  • 16. HTLV-III and the etiology of AIDS.
    Gallo RC; Sarngadharan MG; Popovic M; Shaw GM; Hahn B; Wong-Staal F; Robert-Guroff M; Zaki Salahuddin S; Markham PD
    Prog Allergy; 1986; 37():1-45. PubMed ID: 3008160
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hospital hygiene. Notice of the Expert Federal Commission for AIDS on procedures to adopt in regard to patients with AIDS and to persons carrying anti-LAV/HTLV-III antibodies].
    Krankenpfl Soins Infirm; 1986 May; 79(5):74-5. PubMed ID: 3012197
    [No Abstract]   [Full Text] [Related]  

  • 18. Testing for HTLV-III/LAV antibody.
    Holston JL
    Ala J Med Sci; 1986 Jul; 23(3):269-71. PubMed ID: 3019171
    [No Abstract]   [Full Text] [Related]  

  • 19. Non inflication with LAV/HTLV III in Thai workers.
    Wasi C; Louisirirotchanakul S; Sakulkoo P; Surakhaka M; Chaiprasithikul P; Thongcharoen P
    J Med Assoc Thai; 1986 Jan; 69(1):56. PubMed ID: 3007648
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiviral chemotherapies directed against HTLV-III/LAV.
    Resnick L
    Mt Sinai J Med; 1986 Dec; 53(8):648-56. PubMed ID: 3027545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.